Picture of Median Technologies SA logo

ALMDT Median Technologies SA Share Price

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Momentum

Relative Strength (%)
1m+32.47%
3m-17.34%
6m-28.05%
1yr-55.93%
Volume Change (%)
10d/3m+154.45%
Price vs... (%)
52w High-50.83%
50d MA+15.89%
200d MA-9.88%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-718.19%
Return on Equityn/a
Operating Margin-105.67%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Median Technologies SA EPS forecast chart

Profile Summary

Median Technologies SA is a France-based company that publishes software for the diagnosis and monitoring of cancer patients. The Company develops lesion management solutions (LMS) to objectively measure and track cancerous or suspicious lesions, distribute a standardized oncologic report and centralize the lesion information for multidisciplinary review. The LMS line includes such products as LMS-Lung, a clinical application for the detection, evaluation and follow-up of lesions identified in CT images covering the chest; LMS-Track, a clinical application for the follow-up of oncology patients; and LMS-Liver, a clinical application for the initial evaluation and the follow-up of liver metastases and any other lesions identified in CT images covering the liver. The Company operates one subsidiary, Median Technologies Inc, based in the United States.

Directors

Last Annual
December 31st, 2022
Last Interim
June 30th, 2023
Incorporated
October 1st, 2002
Public Since
May 20th, 2011
No. of Employees
233
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
fr flag iconEuronext - Paris
Shares in Issue
15,749,278

ALMDT Share Price Performance

Upcoming Events for ALMDT

Full Year 2023 Median Technologies SA Earnings Release

Median Technologies SA Annual Shareholders Meeting

Similar to ALMDT

Picture of Affluent Medical SAS logo

Affluent Medical SAS

fr flag iconEuronext - Paris

Picture of Alpha MOS SA logo

Alpha MOS SA

fr flag iconEuronext - Paris

Picture of Amplitude Surgical SA logo

Amplitude Surgical SA

fr flag iconEuronext - Paris

Picture of Biomerieux SA logo

Biomerieux SA

fr flag iconEuronext - Paris

Picture of Biosynex SA logo

Biosynex SA

fr flag iconEuronext - Paris

FAQ